These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16483173

  • 1. Alteration of plasma concentrations of OPG before and after levothyroxine replacement therapy in hypothyroid patients.
    Guang-Da X, Hui-Ling S, Zhi-Song C, Lin-Shuang Z.
    J Endocrinol Invest; 2005 Dec; 28(11):965-72. PubMed ID: 16483173
    [Abstract] [Full Text] [Related]

  • 2. Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients.
    Guang-da X, Hui-ling S, Zhi-song C, Lin-shuang Z.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5765-8. PubMed ID: 16046585
    [Abstract] [Full Text] [Related]

  • 3. [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients].
    Xiang GD, Sun HL, Zhao LS, Hou J, Yue L.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 14; 87(30):2121-5. PubMed ID: 17988532
    [Abstract] [Full Text] [Related]

  • 4. Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.
    Nagasaki T, Inaba M, Jono S, Hiura Y, Tahara H, Shirakawa K, Onoda N, Ishikawa T, Ishimura E, Nishizawa Y.
    Eur J Endocrinol; 2005 Mar 14; 152(3):347-53. PubMed ID: 15757850
    [Abstract] [Full Text] [Related]

  • 5. Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia.
    Guang-da X, Hui-ling S, Jie H.
    Clin Endocrinol (Oxf); 2008 Nov 14; 69(5):799-803. PubMed ID: 18410551
    [Abstract] [Full Text] [Related]

  • 6. The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes.
    Xiang GD, Xu L, Zhao LS, Yue L, Hou J.
    Diabetes; 2006 Jul 14; 55(7):2126-31. PubMed ID: 16804084
    [Abstract] [Full Text] [Related]

  • 7. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C.
    Bone; 2004 Sep 14; 35(3):785-91. PubMed ID: 15336617
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar 14; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

  • 9. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism.
    Xiang G, Xiang L, Xiang L, Wang H, Dong J.
    Exp Clin Endocrinol Diabetes; 2012 Oct 14; 120(9):529-34. PubMed ID: 23070830
    [Abstract] [Full Text] [Related]

  • 10. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun 14; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

  • 11. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications.
    Knudsen ST, Foss CH, Poulsen PL, Andersen NH, Mogensen CE, Rasmussen LM.
    Eur J Endocrinol; 2003 Jul 14; 149(1):39-42. PubMed ID: 12824864
    [Abstract] [Full Text] [Related]

  • 12. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
    Xiang GD, Sun HL, Zhao LS.
    Diabetes Res Clin Pract; 2007 May 14; 76(2):199-206. PubMed ID: 17023086
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy.
    Nagasaki T, Inaba M, Hiura Y, Tahara H, Kumeda Y, Shirakawa K, Onoda N, Ishikawa T, Ishimura E, Nishizawa Y.
    Biomed Pharmacother; 2005 Dec 14; 59(10):571-7. PubMed ID: 16202556
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O, Auldin MA, Agarwal R, Kieffer V, Robertson C, Falconer Smith J, Levy MJ, Howlett TA.
    Clin Endocrinol (Oxf); 2011 Jun 14; 74(6):744-9. PubMed ID: 21521256
    [Abstract] [Full Text] [Related]

  • 15. Changes of plasma concentration of osteoprotegerin and its association with endothelial dysfunction before and after hypouricemic therapy in patients with hyperuricemia.
    Wang HH, Xiang GD.
    Mod Rheumatol; 2015 Jan 14; 25(1):123-7. PubMed ID: 24947824
    [Abstract] [Full Text] [Related]

  • 16. [Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients].
    Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L.
    Zhonghua Yi Xue Za Zhi; 2007 May 15; 87(18):1234-7. PubMed ID: 17686254
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
    Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1999 Mar 15; 84(3):924-9. PubMed ID: 10084572
    [Abstract] [Full Text] [Related]

  • 18. Treating hypothyroidism improves endothelial function.
    Papaioannou GI, Lagasse M, Mather JF, Thompson PD.
    Metabolism; 2004 Mar 15; 53(3):278-9. PubMed ID: 15015136
    [Abstract] [Full Text] [Related]

  • 19. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.
    Akinci B, Comlekci A, Ali Ozcan M, Demir T, Yener S, Demirkan F, Yuksel F, Yesil S.
    Endocr J; 2007 Feb 15; 54(1):45-52. PubMed ID: 17090955
    [Abstract] [Full Text] [Related]

  • 20. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
    Fallahi P, Ferrari SM, Antonelli A.
    Endocr Pract; 2017 Feb 15; 23(2):170-174. PubMed ID: 27849377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.